معرفی
Michael Wang is a Professor in the Department of Pharmaceutical Chemistry at the University of Kansas School of Pharmacy. His research focuses on drug metabolism, antiparasitic agents, mass spectrometry, and pharmacogenomics. He holds a Ph.D. in Analytical Chemistry from Duke University and a B.S. in Chemistry from Peking University.
His work includes developing physiologically-based pharmacokinetic models, studying Leishmania parasite metabolism, and advancing methodologies in proteomics and targeted quantitative analysis. Key projects involve optimizing drug bioavailability for treatments like eflornithine and miltefosine, and investigating CYP enzyme roles in drug metabolism.
Recent studies highlight his involvement in antileishmanial drug development, including CYP51 enzyme inhibition and azole antifungal mechanisms. He collaborates on pharmacogenomics education and has published extensively in journals like Nat Commun, Antimicrob Agents Chemother, and Drug Metab Dispos.
Led research teams in experimental therapeutics for tropical diseases and contributed to methodological advancements in biomarker discovery and exosome analysis.
